473733-26-5

Usage

Uses

Used in Pharmaceutical Synthesis:
(1S)-1-(5-METHYLFURAN-2-YL)ETHAN-1-AMINE is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its unique structure allows it to be a versatile building block in the creation of a wide range of medicinal compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (1S)-1-(5-METHYLFURAN-2-YL)ETHAN-1-AMINE is utilized as a component in the design and synthesis of novel therapeutic agents. Its presence in these compounds can influence their pharmacological properties, potentially leading to the discovery of new treatments for various diseases.
Used in Drug Development:
(1S)-1-(5-METHYLFURAN-2-YL)ETHAN-1-AMINE plays a crucial role in drug development, where it is employed to create new organic compounds with potential therapeutic applications. Its integration into drug candidates can enhance their efficacy, selectivity, and safety profiles, contributing to the advancement of medical treatments.

Relevant academic research and scientific papers

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.